Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 393

    1.

    Obese women and the relation between cardiovascular risk profile and hormone therapy, glucose tolerance, and psychosocial conditions.

    Lidfeldt J, Samsioe G, Agardh CD.

    Diabetes Care. 2006 Nov;29(11):2477-82.PMID: 17065688 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.

    Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, Fujimoto W, Yano K.

    Diabetes Care. 1996 Jun;19(6):587-90.PMID: 8725856 [PubMed - indexed for MEDLINE]Related articles

    3.

    Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.

    Undén AL, Elofsson S, Brismar K.

    Clin Endocrinol (Oxf). 2005 Jul;63(1):94-102.PMID: 15963068 [PubMed - indexed for MEDLINE]Related articles

    4.

    The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?

    Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES.

    Diabetes Care. 2003 Nov;26(11):3024-30.PMID: 14578234 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study.

    Shakir YA, Samsioe G, Khatibi E A, Nyberg P, Lidfeldt J, Agardh CD, Nerbrand C.

    J Womens Health (Larchmt). 2007 Apr;16(3):406-14.PMID: 17439385 [PubMed - indexed for MEDLINE]Related articles

    6.

    Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.

    Larsson H, Ahrén B.

    Diabetes Care. 1996 Dec;19(12):1399-403.PMID: 8941471 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2005 Oct;28(10):2472-9.PMID: 16186282 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain.

    Tamayo-Marco B, Faure-Nogueras E, Roche-Asensio MJ, Rubio-Calvo E, Sánchez-Oriz E, Salvador-Oliván JA.

    Diabetes Care. 1997 Apr;20(4):534-6.PMID: 9096976 [PubMed - indexed for MEDLINE]Related articles

    9.

    Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

    Hanley AJ, Williams K, Stern MP, Haffner SM.

    Diabetes Care. 2002 Jul;25(7):1177-84.PMID: 12087016 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study.

    Braun B, Zimmermann MB, Kretchmer N, Spargo RM, Smith RM, Gracey M.

    Diabetes Care. 1996 May;19(5):472-9.PMID: 8732712 [PubMed - indexed for MEDLINE]Related articles

    11.

    Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.

    Pascot A, Després JP, Lemieux I, Alméras N, Bergeron J, Nadeau A, Prud'homme D, Tremblay A, Lemieux S.

    Diabetes Care. 2001 May;24(5):902-8.PMID: 11347752 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius.

    Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG.

    Diabetes Care. 2000 Sep;23(9):1242-8.PMID: 10977013 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.

    Scarsella C, Alméras N, Mauriège P, Blanchet C, Sauvé L, Dewailly E, Bergeron J, Després JP.

    Can J Cardiol. 2003 Jan;19(1):51-7.PMID: 12571695 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Women living alone have an increased risk to develop diabetes, which is explained mainly by lifestyle factors.

    Lidfeldt J, Nerbrand C, Samsioe G, Agardh CD.

    Diabetes Care. 2005 Oct;28(10):2531-6.PMID: 16186292 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.

    da Silva RC, Miranda WL, Chacra AR, Dib SA.

    J Diabetes Complications. 2007 Mar-Apr;21(2):84-92.PMID: 17331856 [PubMed - indexed for MEDLINE]Related articles

    16.

    Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors.

    Frati AC, Iniestra F, Ariza CR.

    Diabetes Care. 1996 Feb;19(2):112-8.PMID: 8718429 [PubMed - indexed for MEDLINE]Related articles

    17.

    Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.

    Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G.

    Nutr Metab Cardiovasc Dis. 2006 May;16(4):256-62. Epub 2006 Jan 4.PMID: 16679217 [PubMed - indexed for MEDLINE]Related articles

    18.

    High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.

    Piché ME, Lemieux S, Pérusse L, Weisnagel SJ.

    Diabetologia. 2005 Apr;48(4):732-40. Epub 2005 Mar 12.PMID: 15765221 [PubMed - indexed for MEDLINE]Related articles

    19.

    Serum adiponectin concentration and cardiovascular risk factors in climacteric women.

    Milewicz A, Zatonska K, Demissie M, Jêdrzejuk D, Dunajska K, Ilow R, Lwow F.

    Gynecol Endocrinol. 2005 Feb;20(2):68-73.PMID: 15823824 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality.

    Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G.

    Diabetes Care. 2003 Oct;26(10):2883-9.PMID: 14514596 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data